INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

26,449 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
23
LC
Longhito ChristopherFMR SVP & CSCO
GICGLOBAL INDUSTRIAL Co
Open-market sale
SELL$995
32 sh
Mar 27, 2026Apr 1, 2026
Page 452 of 662
← PrevNext →
traded Mar 27, 2026
+5d
SEC Form 4

Evidence

23
ND
Noci DarleneChief Development Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$247K
2,532 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

22
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$1.67M
53.7K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

21
YT
Yaacobi TalDirector
VLNValens Semiconductor Ltd.
Open-market sale
SELL$1,554
1,400 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

20
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.55M
1.00M sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

19
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$1.72M
21.8K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

19
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$196K
6,710 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

16
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.63M
1.00M sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

14
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$21K
4,278 sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

12
BA
Brady James AloysiusDirector
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$60K
10.8K sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

12
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
790 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

9
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$196K
2,366 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$119K
1,485 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$109K
1,390 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$65K
800 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

8
BC
Bird Justin ChristopherExecutive Vice President
SRESEMPRA
Open-market sale · 10b5-1 plan
SELL$109K
1,128 sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

8
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
4,000 sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

3
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
4,000 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

3
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
4,000 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

1
PA
Pena Fernando AustinDirector, President
BXMTBLACKSTONE MORTGAGE TRUST, INC.
Open-market sale · 10b5-1 plan
SELL$31K
1,666 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

51
CE
Carter Charles EdwardChief Regional Officer: Amer.
SBSWSibanye Stillwater Ltd
Open-market purchase
BUY$114K
10.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

50
WS
Weaver Robert S.EVP, Government Relations
NXSTNEXSTAR MEDIA GROUP, INC.
Open-market sale
SELL$399K
1,872 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

50
MR
Morgan RachelEVP General Counsel
NXSTNEXSTAR MEDIA GROUP, INC.
Open-market sale
SELL$668K
3,127 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

47
YF
Yeap Choh FeiSVP
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTD
Open-market purchase
BUY$56K
1,000 sh
Mar 22, 2026Mar 31, 2026
traded Mar 22, 2026
+9dSEC Form 4

Evidence

47
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$434K
2,161 sh
Mar 6, 2026Mar 31, 2026
traded Mar 6, 2026
+25dSEC Form 4

Evidence

46
LS
Lin Shyue-ShyhVP
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTD
Open-market purchase
BUY$164K
3,000 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

44
DD
Degner DennisChief Executive Officer & Pres
RRCRANGE RESOURCES CORP
Open-market sale
SELL$693K
15.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

41
MM
Marks Nataly MichelleDirector
MSIFMSC INCOME FUND, INC.
Open-market purchase
BUY$13K
1,000 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

40
PM
Preston Tracy MEVP, CLO & Corporate Secretary
MMacy's, Inc.
Open-market sale
SELL$49K
2,736 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

40
Mark AlfordRSelf
AMZNAMAZON COM INC
Partial sale
SELL$1,001 – $15KMar 16, 2026Mar 31, 2026
traded Mar 16, 2026
+15dHouse PTR

Evidence

39
BO
Bron OlivierCEO, Bloomingdale's
MMacy's, Inc.
Open-market sale
SELL$54K
3,051 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

39
WG
Weitman GarySee Remarks
NXSTNEXSTAR MEDIA GROUP, INC.
Open-market sale
SELL$214K
1,005 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

38
EH
Employees' Retirement System of the State of Hawaii10% Owner
NANALafayette Square USA, Inc.
Open-market purchase
BUY$4.00M
270.6K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

37
VE
Vanzura ElisabethDirector, CMO
SBDSSolo Brands, Inc.
Open-market purchase
BUY$5,655
1,500 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

37
SJ
Stenberg JonDirector, President & CEO
CIACITIZENS, INC.
Open-market purchase
BUY$235K
50.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

36
MW
McDowell Erin WSVP & General Counsel
RRCRANGE RESOURCES CORP
Open-market sale
SELL$396K
8,250 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

36
DR
Dunn RickChief Financial Officer
SATLSatellogic Inc.
Open-market purchase
BUY$99K
16.7K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

35
SS
Szabo ShandellDirector
MGYMagnolia Oil & Gas Corp
Open-market sale
SELL$375K
11.7K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

35
MS
Manor SagitCFO
NYAXNayax Ltd.
Open-market sale
SELL$69K
1,252 sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

33
HF
Huang Michael F.Sr. VP of Clinical Development
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$128K
4,256 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence